MENU
It has been one year since I became CEO. Over the past year, under the slogan “Reclaiming the Healthcare Industry,” I have worked hard to refocus MEJ’s mission and drive our efforts forward. Now, we are beginning to see real progress and results.
Through the “MExx Initiative,” we are making steady progress in Vietnam, Thailand, and India. Each visit to these countries reinforces the trust and high expectations placed on Japanese healthcare. We are determined to honor this trust with tangible achievements.
In medical inbound services, we are supported by strong national policies, such as the government’s “Basic Policy on Economic and Fiscal Management” and the Ministry of Health’s “Global Health Strategy.” This is a unique opportunity to break new ground and achieve significant growth.
Our Mission is Clear:
•Share Japan’s world-class medical expertise with the world (Outbound).
•Welcome patients, talent, and investments from abroad (Inbound).
This integration of outbound and inbound efforts defines MEJ’s role and purpose.
As protectionism grows, economic security and industrial growth are more connected than ever. Japan must remain open, resilient, and innovative. MEJ, with its unique platform linking public, private, academic, and civic sectors, will play a key role in this effort.
Healthcare is a cornerstone of Japan’s future. We will continue to expand Japan’s healthcare influence globally and bring international trust back to Japan.
Together, let’s build a brighter future. I thank you for your ongoing support and collaboration.
Kenji Shibuya Chief Executive Officer, MEJ
Chief Executive Officer, Medical Excellence JAPAN
Dr. Kenji Shibuya is a renowned expert in the field of global and population health. He currently holds multiple prestigious positions, including Senior Executive Director of Medical Excellence JAPAN, Research Director at the Tokyo Foundation for Policy Research, Managing Director at the Soma COVID Vaccination Medical Center in Soma City, Fukushima, and Venture Partner of Eight Roads Ventures Japan. Previously, Dr. Shibuya served as a Professor and Director of the University Institute for Population Health at King's College London. Before his time at King's, he held the position of Professor and Chair of the Department of Global Health at the University of Tokyo.
Dr. Shibuya possesses a wide range of expertise in various crucial areas of global and population health. His knowledge spans health metrics and evaluation, global burden of disease, health system performance, product and system innovations, public-private partnerships, and R&D strategies. Throughout his career, Dr. Shibuya has been an advisor to both central and local governments.
Notably, he served as a Special Advisor to the Director-General of the World Health Organization (WHO) and was a member of the Scientific Advisory Committee of the Coalition for Epidemic Preparedness Innovations (CEPI), a pandemic vaccine fund that invested in COVID-19 vaccines.
Dr. Shibuya played a pivotal role in shaping the strategic directions of Japanese global health policy. He spearheaded discussions on health system strengthening at the Hokkaido Toyako G8 Summit in 2008 and global health security at the Ise-Shima G7 Summit in 2016.
He completed his medical degree at the University of Tokyo and earned a doctorate of public health in international health economics from Harvard University.